ifosfamide has been researched along with Cholera Infantum in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three patients with stage 4 neuroblastoma were treated with a schedule comprising alternating modules of myelosuppressive (ifosfamide, etoposide, doxorubicin) and less myelosuppressive (vincristine, cisplatin) drugs given every 10 days regardless of the neutrophil count." | 9.07 | Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin. ( Craft, AW; Lowis, SP; Pearson, AD; Reid, MM, 1993) |
| "Seven treatment-related deaths due to septicemia (three), cardiac arrhythmia (one), pneumonia (one), pneumonitis (one), and toxic epidermal necrolysis (one) were observed." | 6.73 | Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. ( Ebeling, P; Metz, K; Moritz, T; Müller, S; Nowrousian, MR; Passon, J; Schütt, P; Seeber, S; Welt, A, 2007) |
| "Three patients with stage 4 neuroblastoma were treated with a schedule comprising alternating modules of myelosuppressive (ifosfamide, etoposide, doxorubicin) and less myelosuppressive (vincristine, cisplatin) drugs given every 10 days regardless of the neutrophil count." | 5.07 | Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin. ( Craft, AW; Lowis, SP; Pearson, AD; Reid, MM, 1993) |
| "Seven treatment-related deaths due to septicemia (three), cardiac arrhythmia (one), pneumonia (one), pneumonitis (one), and toxic epidermal necrolysis (one) were observed." | 2.73 | Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. ( Ebeling, P; Metz, K; Moritz, T; Müller, S; Nowrousian, MR; Passon, J; Schütt, P; Seeber, S; Welt, A, 2007) |
| " The aim of this study was to assess the efficacy and safety of ifosfamide in combination with carboplatin and etoposide (ICE) in previously untreated patients with SCLC." | 1.42 | Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer. ( Koo, DH; Lee, HS; Lee, SS; Lee, YG; Lim, SY; Nam, H; Oh, S; Song, JU, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HS | 1 |
| Lee, YG | 1 |
| Koo, DH | 1 |
| Oh, S | 1 |
| Nam, H | 1 |
| Song, JU | 1 |
| Lim, SY | 2 |
| Lee, SS | 1 |
| Marx, G | 1 |
| Lewis, C | 1 |
| Hall, K | 1 |
| Levi, J | 1 |
| Ackland, S | 1 |
| Boutemy, M | 1 |
| Mispelaere, D | 1 |
| Krzisch, C | 1 |
| Jounieaux, V | 1 |
| Schütt, P | 1 |
| Passon, J | 1 |
| Ebeling, P | 1 |
| Welt, A | 1 |
| Müller, S | 1 |
| Metz, K | 1 |
| Moritz, T | 1 |
| Seeber, S | 1 |
| Nowrousian, MR | 1 |
| Todisco, E | 1 |
| Castagna, L | 1 |
| Sarina, B | 1 |
| Mazza, R | 1 |
| Magagnoli, M | 1 |
| Balzarotti, M | 1 |
| Nozza, A | 1 |
| Siracusano, L | 1 |
| Timofeeva, I | 1 |
| Anastasia, A | 1 |
| Demarco, M | 1 |
| Santoro, A | 1 |
| Serrou, B | 1 |
| Cupissol, D | 1 |
| Plagne, R | 1 |
| Boutin, P | 1 |
| Carcassone, Y | 1 |
| Michel, FB | 1 |
| Valdivieso, M | 1 |
| Bodey, GP | 1 |
| Benjamin, RS | 1 |
| Barkley, HT | 1 |
| Freeman, MB | 1 |
| Ertel, M | 1 |
| Smith, TL | 1 |
| Mountain, CF | 1 |
| Loehrer, PJ | 1 |
| Williams, SD | 1 |
| Einhorn, LH | 1 |
| Lowis, SP | 1 |
| Pearson, AD | 1 |
| Reid, MM | 1 |
| Craft, AW | 1 |
| Hoelzer, D | 1 |
| Ludwig, WD | 1 |
| Thiel, E | 1 |
| Gassmann, W | 1 |
| Löffler, H | 1 |
| Fonatsch, C | 1 |
| Rieder, H | 1 |
| Heil, G | 1 |
| Heinze, B | 1 |
| Arnold, R | 1 |
| Hossfeld, D | 1 |
| Büchner, T | 1 |
| Koch, P | 1 |
| Freund, M | 1 |
| Hiddemann, W | 1 |
| Maschmeyer, G | 1 |
| Heyll, A | 1 |
| Aul, C | 1 |
| Faak, T | 1 |
| Kuse, R | 1 |
| Ittel, TH | 1 |
| Gramatzki, M | 1 |
| Diedrich, H | 1 |
| Kolbe, K | 1 |
| Fuhr, HG | 1 |
| Fischer, K | 1 |
| Schadeck-Gressel, C | 1 |
| Weiss, A | 1 |
| Strohscheer, I | 1 |
| Metzner, B | 1 |
| Fabry, U | 1 |
| Gökbuget, N | 1 |
| Völkers, B | 1 |
| Messerer, D | 1 |
| Uberla, K | 1 |
| Welte, K | 1 |
| Reiter, A | 1 |
| Mempel, K | 1 |
| Pfetsch, M | 1 |
| Schwab, G | 1 |
| Schrappe, M | 1 |
| Riehm, H | 1 |
| De Giorgi, U | 1 |
| Rosti, G | 1 |
| Papiani, G | 1 |
| Marangolo, M | 1 |
| Abu-Ghosh, AM | 1 |
| Krailo, MD | 1 |
| Goldman, SC | 1 |
| Slack, RS | 1 |
| Davenport, V | 1 |
| Morris, E | 1 |
| Laver, JH | 1 |
| Reaman, GH | 1 |
| Cairo, MS | 1 |
| Burkert, H | 1 |
| Schnitker, J | 1 |
| Fichtner, E | 1 |
| Dumontet, C | 1 |
| Biron, P | 1 |
| Bouffet, E | 1 |
| Blay, JY | 1 |
| Meckenstock, R | 1 |
| Chauvin, F | 1 |
| Philip, I | 1 |
| Clavel, M | 1 |
| Brunat-Mentigny, M | 1 |
| Philip, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)[NCT00388193] | Phase 2 | 20 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
| Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.[NCT05049473] | Phase 2 | 100 participants (Anticipated) | Interventional | 2014-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ifosfamide and Cholera Infantum
| Article | Year |
|---|---|
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical T | 2002 |
8 trials available for ifosfamide and Cholera Infantum
| Article | Year |
|---|---|
Phase I study of docetaxel plus ifosfamide in patients with advanced cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Respons | 2002 |
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Thera | 2007 |
CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Muri | 2007 |
Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marr | 1981 |
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bon | 1981 |
Prohibitive toxicity of a dose-intense regime for metastatic neuroblastoma containing ifosfamide, doxorubicin and cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child, Preschool; C | 1993 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1996 |
Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide | 2002 |
6 other studies available for ifosfamide and Cholera Infantum
| Article | Year |
|---|---|
Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma | 2015 |
[Evaluation of combined chemotherapy with vinorelbine, ifosfamide and cisplatin in the treatment of metastatic non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcin | 2005 |
N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
Topics: Acetylcysteine; Adenocarcinoma; Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combin | 1983 |
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone | 1996 |
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone | 1996 |
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone | 1996 |
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone | 1996 |
[Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
Topics: Adolescent; Adult; Aged; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Gastrointestinal Dise | 1979 |
High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chil | 1992 |